Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

PURE — PURE Bioscience, Inc. Dilution Risk Tracker

Track PURE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PURE — Get alerts when the score changes →

As of October 13, 2026, PURE Bioscience, Inc. (PURE) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. PURE Bioscience, Inc. has a market capitalization of $10.40M, 130.02M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
32
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 45%
🔄 Reverse Split model est. 70%
• 50-day avg $0.08 below $1 exchange minimum
• Only 6 months cash — financial pressure
💰 Capital Raise model 35%
• Low cash runway: 6 months remaining
🔔 Track PURE — Get forecast alerts →

Market Data

Market Cap$10.40M
Shares Outstanding130.02M
Float72.16M
Cash$983.0K
Debt$6.14M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding130.02MVerified float table or market cache
Public Float72.16MVerified float table or market cache
Market Cap$10.40MMarket data cache
Cash Runway5.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest19.3K
Days to Cover1.0
% of Float0.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-15
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PURE Dilution Snapshot

PURE Bioscience, Inc. (PURE) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PURE's DilutionScore is currently 50/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 52/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202650/100MEDIUM53 days
Aug 14 – Aug 21, 202652/100HIGH7 days
Jul 16 – Aug 13, 202650/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track PURE Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PURE files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PURE — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations